NasdaqGS - Nasdaq Real Time Price • USD
Acumen Pharmaceuticals, Inc. (ABOS)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 5:35 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARTON RUSSELL Chief Operating Officer | Sale | Jan 18, 2024 | 96,867 |
| HARDIE ROBERT D Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 6, 2021 | -- |
| IVES JEFFREY L Director | Sale | Aug 17, 2023 | -- |
| MANNING PAUL B. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 6, 2021 | -- |
| MEISNER DEREK M Officer | Sale | Jan 19, 2024 | 108,867 |
| O'CONNELL DANIEL JOSEPH Chief Executive Officer | Sale | Jan 19, 2024 | 502,485 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 21, 2023 | -- |
| SIEMERS ERIC M.D. Officer | Sale | Jan 18, 2024 | 117,576 |
| STALFORT JOHN A III Director | Purchase | Jul 6, 2021 | 303,919 |
| ZUGA MATT Chief Executive Officer | Sale | Jan 18, 2024 | 211,445 |
Related Tickers
KZR Kezar Life Sciences, Inc.
0.7876
-3.55%
PMN ProMIS Neurosciences, Inc.
1.9999
+6.38%
CMRX Chimerix, Inc.
0.9323
+3.13%
ALGS Aligos Therapeutics, Inc.
0.7931
+0.78%
DSGN Design Therapeutics, Inc.
3.7400
-5.08%
AADI Aadi Bioscience, Inc.
1.8000
-1.10%
ETNB 89bio, Inc.
8.88
-3.06%
AVTE Aerovate Therapeutics, Inc.
21.60
-4.00%
EWTX Edgewise Therapeutics, Inc.
15.45
-1.28%
BOLT Bolt Biotherapeutics, Inc.
1.1400
+2.70%